33 results on '"Nielsen L"'
Search Results
2. Cost-effectiveness of 12 weeks of supervised treatment compared to written advice in patients with knee osteoarthritis: a secondary analysis of the 2-year outcome from a randomized trial
3. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis
4. Total knee replacement and non-surgical treatment of knee osteoarthritis: 2-year outcome from two parallel randomized controlled trials
5. The association between histological, macroscopic and magnetic resonance imaging assessed synovitis in end-stage knee osteoarthritis: a cross-sectional study
6. The efficacy of non-surgical treatment on pain and sensitization in patients with knee osteoarthritis: a pre-defined ancillary analysis from a randomized controlled trial
7. The efficacy of 12 weeks non-surgical treatment for patients not eligible for total knee replacement: a randomized controlled trial with 1-year follow-up
8. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover
9. Quantitative sensory testing in painful osteoarthritis: a systematic review and meta-analysis
10. 5-YEAR FOLLOW-UP OF PATIENTS WITH KNEE OSTEOARTHRITIS RECEIVING NON-SURGICAL TREATMENT: RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
11. Pre-treatment pain sensitivity is associated with outcome following exercise therapy in patients with knee osteoarthritis - an observational study
12. Chronic pain in pre and post total knee arthroplasty
13. Associations between physical performances, self-reported outcomes, and quantitative sensory testing in patients with chronic pain after knee osteoarthritis and total knee arthroplasty
14. Study protocol for a randomized controlled trial of neuromuscular exercise and pain neuroscience education in patients with chronic pain after total knee arthroplasty
15. 2-year cost-effectiveness of total knee replacement: results from the first randomized trial on total knee replacement in addition to non-surgical treatment
16. Multimodal rehabilitation in patients with persistent pain and functional disability after primary or revision total knee arthroplasty
17. Response to Letter to Editor: ‘2-year outcome from two parallel randomized controlled trials. Reporting considerations’
18. A biomarker of hypertrophic chondrocytes, type X collagen, completely distinguishes between OA and RA
19. Two year outcome from two parallel randomized trials on total knee replacement and non-surgical treatment of knee osteoarthritis
20. The two-year efficacy of 12-weeks non-surgical treatment for patients not eligible for total knee replacement – A pre-defined analysis from a randomized controlled trial
21. Degradation of isomerized type II collagen – A highly specific marker for joint destruction that can distinguish between different rheumatic pathologies
22. A novel serological type III collagen a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) degradation marker for assessment of the extracellular matrix remodeling in patients with osteoarthritis
23. Total knee replacement followed by a non-surgical treatment program reduce localized and spreading pain sensitization – A pre-defined ancillary analysis from a randomized controlled trial
24. Neural correlates of temporal summation in knee osteoarthritis pain: a preliminary FMRI study at 3T
25. The combined efficacy of multimodal non-surgical treatment on pain and sensitization in patients with knee osteoarthritis not eligible for a total knee arthroplasty – An ancillary analysis from a randomized controlled trial
26. A single center, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy and safety of intra-articular onabotulinumtoxina as treatment for osteoarthritis knee pain: results from the experimental pain models
27. Synovitis, pain and serological biomarkers
28. Sensitization and pain over two years: the multicenter osteoarthritis (most) study
29. Results from a single center, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy and safety of intra-articular onabotulinumtoxina for osteoarthritis knee pain
30. Segregation of OA patients into different treatment groups based on their level of systemic and tissue-specific inflammation
31. 56 THE ASSOCIATION OF PERIPHERAL AND CENTRAL SENSITIZATION WITH MUSCLE CO-ACTIVATION: A COMMON MECHANISM AFFECTING PAIN AND FUNCTION IN KNEE OA?
32. 034 CENTRAL SENSITIZATION IN KNEE OA: PRELIMINARY RESULTS FROM THE MOST STUDY
33. P356 SPATIAL SUMMATION OF PAIN ASSESSED BY COMPUTERIZED CUFF PRESSURE ALGOMETRY IS NOT FACILITATED IN PATIENTS WITH KNEE OSTEOARTHRITIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.